NCT04489355

Brief Summary

The study focuses on the development of a new personalized approach to diagnostics and surgical treatment of patients with ischemic cardiomyopathy. The algorithm for selection of patients for certain type of cardiac surgery will be developed. The models for prediction of the risks and outcomes of cardiac surgery will be elaborated to reduce the rate of complications in the early and long-term postoperative period in patients with ischemic cardiomyopathy. Imaging modalities, methods for assessement of structural and functional state of the myocardium, biochemistry testing, immunohistochemical examination, and myocardial biopsy studies will be used to achieve these goals.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
260

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2013

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 28, 2013

Completed
7.5 years until next milestone

First Submitted

Initial submission to the registry

July 23, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 28, 2020

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 28, 2023

Completed
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2024

Completed
Last Updated

June 26, 2026

Status Verified

June 1, 2026

Enrollment Period

10 years

First QC Date

July 23, 2020

Last Update Submit

June 23, 2026

Conditions

Keywords

Chronic heart failureIschemic cardiomyopathy

Outcome Measures

Primary Outcomes (2)

  • Number of participants with postoperative left ventricular remodeling according to echocardiography.

    Number of participants with a decrease in left ventricular end-systolic volume by 15% or more.

    12 months

  • Cardiac death

    Cardiac death, %

    12 months

Secondary Outcomes (1)

  • Number of participants with increased exercise tolerance

    12 months

Study Arms (4)

CABG

The patients with ischemic cardiomyopathy underwent coronary artery bypass graft (CABG)

Procedure: coronary artery bypass graft (CABG) with surgical ventricular restoration (SVR) and mitral repair (MR)

CABG with SVR

The patients with ischemic cardiomyopathy underwent coronary artery bypass graft (CABG) with surgical ventricular restoration (SVR)

Procedure: coronary artery bypass graft (CABG) with surgical ventricular restoration (SVR) and mitral repair (MR)

CABG with mitral repair

The patients with ischemic cardiomyopathy underwent coronary artery bypass graft (CABG) with and mitral repair (MR)

Procedure: coronary artery bypass graft (CABG) with surgical ventricular restoration (SVR) and mitral repair (MR)

CABG with SVR and mitral repair

The patients with ischemic cardiomyopathy underwent coronary artery bypass graft (CABG) with surgical ventricular restoration (SVR) and mitral repair (MR)

Procedure: coronary artery bypass graft (CABG) with surgical ventricular restoration (SVR) and mitral repair (MR)

Interventions

CABGCABG with SVRCABG with SVR and mitral repairCABG with mitral repair

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with ischemic cardiomyopathy with indications for cardiac surgery

You may qualify if:

  • left ventricular ejection fraction less than or equal to 40%; a history of myocardial infarction with a duration of more than 3 months and/or stenosis of more than 75% of the trunk of the left coronary artery, or proximal stenosis of the anterior descending artery and/or stenosis of more than 75% of two or more coronary arteries; final LV systolic index greater than or equal to 60 ml / m2 according to echocardiography, age 18-70 years

You may not qualify if:

  • the presence of organic heart defects of rheumatic and infectious etiology; acute myocardial infarction; less than 3 months after acute coronary or cerebrovascular events; severe pulmonary hypertension not associated with mitral regurgitation (above 75 mmHg); contraindications for operations with cardiopulmonary bypass; chronic alcoholism (including alcoholic damage to the heart), mental disorders; severe course of bronchial asthma, chronic obstructive pulmonary disease in the acute stage; oncological diseases in the terminal stage, refusal of the patient or relatives to participate in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tomsk National Research Medical Center of the Russian Academy of Sciences

Tomsk, 634012, Russia

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

Myocardial biopsy: it is planned to intraoperatively collect myocardial biopsy samples from patients with ischemic cardiomyopathy. In case of aneurysmectomy and myocardial biopsy in the middle parts of the left ventricle of the anterior, posterior, lateral walls and interventricular septum on the side of the endocardium, the wall of the aneurysm and the portion of the right atrial appendage, in the absence of an aneurysm, only the portion of the right atrial appendage.

MeSH Terms

Conditions

Cardiovascular Diseases

Interventions

Coronary Artery Bypass

Intervention Hierarchy (Ancestors)

Myocardial RevascularizationCardiac Surgical ProceduresCardiovascular Surgical ProceduresSurgical Procedures, OperativeVascular GraftingVascular Surgical ProceduresThoracic Surgical Procedures

Study Officials

  • Vladimir M Shipulin, MD, PhD

    Cardiology Research Institute, Tomsk NRMC

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 23, 2020

First Posted

July 28, 2020

Study Start

January 28, 2013

Primary Completion

January 28, 2023

Study Completion

May 1, 2024

Last Updated

June 26, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will share

Deidentified individual participant data (text, tables, figures, and appendices), underlying the results of the trial, will be shared with researchers to achieve the aims in the approved proposal.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
Proposals may be submitted up to 36 months following publication of the results of the trial. After 36 months, the data will be available in the Center's data ware house but without investigator support other than deposited metadata.
Access Criteria
Information regarding submitting proposals and accessing data may be requested from the principal investigator by e-mail.

Locations